APO Research
Talk to an analyst

APO RESEARCH · REPORT

Therapeutic Drug Monitoring

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Selected research

Market Outlook & Growth Opportunities

Global Therapeutic Drug Monitoring Market Outlook and Growth Opportunities 2026

1 January 2026195 pages

Choose your research edition.

Industry ResearchTherapeutic Drug Monitoring Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Therapeutic Drug Monitoring Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Therapeutic Drug Monitoring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Therapeutic Drug Monitoring Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Therapeutic Drug Monitoring Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient's bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects. The process of TDM is predicated on the assumption that there is a definable relationship between dose and plasma or blood drug concentration, and between concentration and therapeutic effects. TDM begins when the drug is first prescribed, and involves determining an initial dosage regimen appropriate for the clinical condition and such patient characteristics as age, weight, organ function, and concomitant drug therapy. When interpreting concentration measurements, factors that need to be considered include the sampling time in relation to drug dose, dosage history, patient response, and the desired medicinal targets. The goal of TDM is to use appropriate concentrations of difficult-to-manage medications to optimize clinical outcomes in patients in various clinical situations.

Roche, Danaher and Abbott are the major companies in the industry, accounting for 17.17%, 10.36% and 8.29% of the revenue respectively in 2019. By region, North America had the highest share of income, reaching 42.31 percent in 2019.

This report provides an overview of the global Therapeutic Drug Monitoring market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Therapeutic Drug Monitoring and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Therapeutic Drug Monitoring revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Therapeutic Drug Monitoring market.

Therapeutic Drug Monitoring Segment by Company

Roche

Danaher

Abbott

Thermo Fisher Scientific

Siemens Healthcare

Bio-Rad Laboratories

BioMerieux

Sanquin

Becton Dickinson

Quest Diagnostics

Therapeutic Drug Monitoring Segment by Type

Blood Test

Urine Test

Saliva Test

Other Test

Therapeutic Drug Monitoring Segment by Application

Hospital Labs

Private Labs

Others

Therapeutic Drug Monitoring Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Therapeutic Drug Monitoring status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Therapeutic Drug Monitoring key companies, revenue, market share, and recent developments.

3. To split the Therapeutic Drug Monitoring breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Therapeutic Drug Monitoring market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Therapeutic Drug Monitoring significant trends, drivers, influence factors in global and regions.

6. To analyze Therapeutic Drug Monitoring competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Drug Monitoring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Drug Monitoring and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Drug Monitoring.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Therapeutic Drug Monitoring industry.

Chapter 3: Detailed analysis of Therapeutic Drug Monitoring company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Therapeutic Drug Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Therapeutic Drug Monitoring in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Therapeutic Drug Monitoring Industry Trends Table 2. Therapeutic Drug Monitoring Industry Drivers Table 3. Therapeutic Drug Monitoring Industry Opportunities and Challenges Table 4. Therapeutic Drug Monitoring Industry Restraints Table 5. Global Therapeutic Drug Monitoring Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Therapeutic Drug Monitoring Revenue Share by Company (2021-2026) Table 7. Global Therapeutic Drug Monitoring Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Therapeutic Drug Monitoring Key Company Manufacturing Base & Headquarters Table 9. Global Therapeutic Drug Monitoring Company, Product Type & Application Table 10. Global Therapeutic Drug Monitoring Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Therapeutic Drug Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Blood Test Table 15. Significant Companies of Urine Test Table 16. Significant Companies of Saliva Test Table 17. Significant Companies of Other Test Table 18. Global Therapeutic Drug Monitoring Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Therapeutic Drug Monitoring Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Therapeutic Drug Monitoring Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Therapeutic Drug Monitoring Sales Value Share by Type (2021-2026) Table 22. Global Therapeutic Drug Monitoring Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Hospital Labs Table 24. Significant Companies of Private Labs Table 25. Significant Companies of Others Table 26. Global Therapeutic Drug Monitoring Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Therapeutic Drug Monitoring Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Therapeutic Drug Monitoring Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Therapeutic Drug Monitoring Sales Value Share by Application (2021-2026) Table 30. Global Therapeutic Drug Monitoring Sales Value Share by Application (2027-2032) Table 31. Global Therapeutic Drug Monitoring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Therapeutic Drug Monitoring Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Therapeutic Drug Monitoring Sales Value Share by Region (2021-2026) Table 34. Global Therapeutic Drug Monitoring Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Therapeutic Drug Monitoring Sales Value Share by Region (2027-2032) Table 36. Global Therapeutic Drug Monitoring Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Therapeutic Drug Monitoring Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Therapeutic Drug Monitoring Sales Value Market Share by Country (2021-2026) Table 39. Global Therapeutic Drug Monitoring Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Therapeutic Drug Monitoring Sales Value Market Share by Country (2027-2032) Table 41. Roche Company Information Table 42. Roche Business Overview Table 43. Roche Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Roche Therapeutic Drug Monitoring Product Portfolio Table 45. Roche Recent Development Table 46. Danaher Company Information Table 47. Danaher Business Overview Table 48. Danaher Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Danaher Therapeutic Drug Monitoring Product Portfolio Table 50. Danaher Recent Development Table 51. Abbott Company Information Table 52. Abbott Business Overview Table 53. Abbott Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Abbott Therapeutic Drug Monitoring Product Portfolio Table 55. Abbott Recent Development Table 56. Thermo Fisher Scientific Company Information Table 57. Thermo Fisher Scientific Business Overview Table 58. Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio Table 60. Thermo Fisher Scientific Recent Development Table 61. Siemens Healthcare Company Information Table 62. Siemens Healthcare Business Overview Table 63. Siemens Healthcare Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio Table 65. Siemens Healthcare Recent Development Table 66. Bio-Rad Laboratories Company Information Table 67. Bio-Rad Laboratories Business Overview Table 68. Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio Table 70. Bio-Rad Laboratories Recent Development Table 71. BioMerieux Company Information Table 72. BioMerieux Business Overview Table 73. BioMerieux Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. BioMerieux Therapeutic Drug Monitoring Product Portfolio Table 75. BioMerieux Recent Development Table 76. Sanquin Company Information Table 77. Sanquin Business Overview Table 78. Sanquin Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Sanquin Therapeutic Drug Monitoring Product Portfolio Table 80. Sanquin Recent Development Table 81. Becton Dickinson Company Information Table 82. Becton Dickinson Business Overview Table 83. Becton Dickinson Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Becton Dickinson Therapeutic Drug Monitoring Product Portfolio Table 85. Becton Dickinson Recent Development Table 86. Quest Diagnostics Company Information Table 87. Quest Diagnostics Business Overview Table 88. Quest Diagnostics Therapeutic Drug Monitoring Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio Table 90. Quest Diagnostics Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Therapeutic Drug Monitoring Product Image Figure 2. Global Therapeutic Drug Monitoring Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Therapeutic Drug Monitoring Market Size (2021-2032) & (US$ Million) Figure 4. Global Therapeutic Drug Monitoring Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Blood Test Image Figure 8. Urine Test Image Figure 9. Saliva Test Image Figure 10. Other Test Image Figure 11. Global Therapeutic Drug Monitoring Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Therapeutic Drug Monitoring Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Therapeutic Drug Monitoring Sales Value Share by Type (2021-2032) Figure 14. Hospital Labs Image Figure 15. Private Labs Image Figure 16. Others Image Figure 17. Global Therapeutic Drug Monitoring Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Therapeutic Drug Monitoring Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Therapeutic Drug Monitoring Sales Value Share by Application (2021-2032) Figure 20. Global Therapeutic Drug Monitoring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Therapeutic Drug Monitoring Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Therapeutic Drug Monitoring Sales Value (2021-2032) & (US$ Million) Figure 23. North America Therapeutic Drug Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Therapeutic Drug Monitoring Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Therapeutic Drug Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Therapeutic Drug Monitoring Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Therapeutic Drug Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Therapeutic Drug Monitoring Sales Value (2021-2032) & (US$ Million) Figure 29. South America Therapeutic Drug Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Therapeutic Drug Monitoring Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Therapeutic Drug Monitoring Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Test
  • Urine Test
  • Saliva Test
  • Other Test
Applications
  • Hospital Labs
  • Private Labs
  • Others
Companies covered
  • Roche
  • Danaher
  • Abbott
  • Thermo Fisher Scientific
  • Siemens Healthcare
  • Bio-Rad Laboratories
  • BioMerieux
  • Sanquin
  • Becton Dickinson
  • Quest Diagnostics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Therapeutic Drug Monitoring Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Therapeutic Drug Monitoring Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Therapeutic Drug Monitoring Market Dynamics
  1. 2.1 Therapeutic Drug Monitoring Industry Trends
  2. 2.2 Therapeutic Drug Monitoring Industry Drivers
  3. 2.3 Therapeutic Drug Monitoring Industry Opportunities and Challenges
  4. 2.4 Therapeutic Drug Monitoring Industry Restraints
3 Therapeutic Drug Monitoring Market by Company
  1. 3.1 Global Therapeutic Drug Monitoring Company Revenue Ranking in 2025
  2. 3.2 Global Therapeutic Drug Monitoring Revenue by Company (2021-2026)
  3. 3.3 Global Therapeutic Drug Monitoring Company Ranking (2024-2026)
  4. 3.4 Global Therapeutic Drug Monitoring Company Manufacturing Base and Headquarters
  5. 3.5 Global Therapeutic Drug Monitoring Company Product Type and Application
  6. 3.6 Global Therapeutic Drug Monitoring Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Therapeutic Drug Monitoring Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Therapeutic Drug Monitoring Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Therapeutic Drug Monitoring Market by Type
  1. 4.1 Therapeutic Drug Monitoring Type Introduction
  2. 4.1.1 Blood Test
  3. 4.1.2 Urine Test
  4. 4.1.3 Saliva Test
  5. 4.1.4 Other Test
  6. 4.2 Global Therapeutic Drug Monitoring Sales Value by Type
  7. 4.2.1 Global Therapeutic Drug Monitoring Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Therapeutic Drug Monitoring Sales Value by Type (2021-2032)
  9. 4.2.3 Global Therapeutic Drug Monitoring Sales Value Share by Type (2021-2032)
5 Therapeutic Drug Monitoring Market by Application
  1. 5.1 Therapeutic Drug Monitoring Application Introduction
  2. 5.1.1 Hospital Labs
  3. 5.1.2 Private Labs
  4. 5.1.3 Others
  5. 5.2 Global Therapeutic Drug Monitoring Sales Value by Application
  6. 5.2.1 Global Therapeutic Drug Monitoring Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Therapeutic Drug Monitoring Sales Value by Application (2021-2032)
  8. 5.2.3 Global Therapeutic Drug Monitoring Sales Value Share by Application (2021-2032)
6 Therapeutic Drug Monitoring Regional Value Analysis
  1. 6.1 Global Therapeutic Drug Monitoring Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Therapeutic Drug Monitoring Sales Value by Region (2021-2032)
  3. 6.2.1 Global Therapeutic Drug Monitoring Sales Value by Region: 2021-2026
  4. 6.2.2 Global Therapeutic Drug Monitoring Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Therapeutic Drug Monitoring Sales Value (2021-2032)
  7. 6.3.2 North America Therapeutic Drug Monitoring Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Therapeutic Drug Monitoring Sales Value (2021-2032)
  10. 6.4.2 Europe Therapeutic Drug Monitoring Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Therapeutic Drug Monitoring Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Therapeutic Drug Monitoring Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Therapeutic Drug Monitoring Sales Value (2021-2032)
  16. 6.6.2 South America Therapeutic Drug Monitoring Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Therapeutic Drug Monitoring Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Therapeutic Drug Monitoring Sales Value Share by Country, 2025 VS 2032
7 Therapeutic Drug Monitoring Country-level Value Analysis
  1. 7.1 Global Therapeutic Drug Monitoring Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Therapeutic Drug Monitoring Sales Value by Country (2021-2032)
  3. 7.2.1 Global Therapeutic Drug Monitoring Sales Value by Country (2021-2026)
  4. 7.2.2 Global Therapeutic Drug Monitoring Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Therapeutic Drug Monitoring Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Therapeutic Drug Monitoring Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Therapeutic Drug Monitoring Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Therapeutic Drug Monitoring Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Danaher
  8. 8.2.1 Danaher Company Information
  9. 8.2.2 Danaher Business Overview
  10. 8.2.3 Danaher Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Danaher Therapeutic Drug Monitoring Product Portfolio
  12. 8.2.5 Danaher Recent Developments
  13. 8.3 Abbott
  14. 8.3.1 Abbott Company Information
  15. 8.3.2 Abbott Business Overview
  16. 8.3.3 Abbott Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Abbott Therapeutic Drug Monitoring Product Portfolio
  18. 8.3.5 Abbott Recent Developments
  19. 8.4 Thermo Fisher Scientific
  20. 8.4.1 Thermo Fisher Scientific Company Information
  21. 8.4.2 Thermo Fisher Scientific Business Overview
  22. 8.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Thermo Fisher Scientific Therapeutic Drug Monitoring Product Portfolio
  24. 8.4.5 Thermo Fisher Scientific Recent Developments
  25. 8.5 Siemens Healthcare
  26. 8.5.1 Siemens Healthcare Company Information
  27. 8.5.2 Siemens Healthcare Business Overview
  28. 8.5.3 Siemens Healthcare Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthcare Therapeutic Drug Monitoring Product Portfolio
  30. 8.5.5 Siemens Healthcare Recent Developments
  31. 8.6 Bio-Rad Laboratories
  32. 8.6.1 Bio-Rad Laboratories Company Information
  33. 8.6.2 Bio-Rad Laboratories Business Overview
  34. 8.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bio-Rad Laboratories Therapeutic Drug Monitoring Product Portfolio
  36. 8.6.5 Bio-Rad Laboratories Recent Developments
  37. 8.7 BioMerieux
  38. 8.7.1 BioMerieux Company Information
  39. 8.7.2 BioMerieux Business Overview
  40. 8.7.3 BioMerieux Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BioMerieux Therapeutic Drug Monitoring Product Portfolio
  42. 8.7.5 BioMerieux Recent Developments
  43. 8.8 Sanquin
  44. 8.8.1 Sanquin Company Information
  45. 8.8.2 Sanquin Business Overview
  46. 8.8.3 Sanquin Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sanquin Therapeutic Drug Monitoring Product Portfolio
  48. 8.8.5 Sanquin Recent Developments
  49. 8.9 Becton Dickinson
  50. 8.9.1 Becton Dickinson Company Information
  51. 8.9.2 Becton Dickinson Business Overview
  52. 8.9.3 Becton Dickinson Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Becton Dickinson Therapeutic Drug Monitoring Product Portfolio
  54. 8.9.5 Becton Dickinson Recent Developments
  55. 8.10 Quest Diagnostics
  56. 8.10.1 Quest Diagnostics Company Information
  57. 8.10.2 Quest Diagnostics Business Overview
  58. 8.10.3 Quest Diagnostics Therapeutic Drug Monitoring Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Quest Diagnostics Therapeutic Drug Monitoring Product Portfolio
  60. 8.10.5 Quest Diagnostics Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst